Skip to content
ApprovedFDA approvedStrong evidence

Donepezil

Prescription Alzheimer's medicine that slows the breakdown of acetylcholine; it eases symptoms but does not stop the disease.

NootropicCholinergicCholinergicMemoryAcetylcholinenoo.affects.memory
Available at

The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

Pharmacology

ClassCholinergic · Memory
Primary targetSelective reversible acetylcholinesterase inhibition
Targets4 receptor targets
Half-lifeApproximately 70 hours, which enables once-daily dosing
OnsetPeak plasma concentration is reached in 3-4 hours; the clinical cognitive effect develops over weeks
EvidenceStrong evidence
Affected systemsAcetylcholinenoo.affects.memory

Contents

DETAILED OVERVIEW

What is Donepezil?

Donepezil is a prescription medicine approved in the United States and the European Union to treat the symptoms of Alzheimer's disease in its mild, moderate and severe stages. It does not stop the disease from progressing; it eases the symptoms. It is also known as Aricept.

It blocks the enzyme that breaks down acetylcholine (one of the brain's chemical messengers), so more of it stays between nerve cells. This partly makes up for the loss of the acetylcholine-using nerve cells that die off in Alzheimer's disease. In large clinical trials it brought a modest but real improvement in thinking and in everyday tasks. The most common complaints are nausea, diarrhea and loss of appetite. It can also cause a slow heartbeat and fainting, so it must not be used when the heart's conduction is disturbed or the heartbeat is markedly slow. In pregnancy and breastfeeding it should be used only after a doctor has weighed the risks.

Mechanism

Reversible AChE inhibitor (raises acetylcholine)

Half-life

~70 hours (once-daily dosing)

Legal status

Prescription medicine (FDA/EMA)

Receptor profile

  • Acetylcholinesterase (AChE)Strong
  • Cholinergic signaling (cortex, hippocampus)Strong
  • Sigma-1 receptorsModerate
  • Nicotinic acetylcholine receptors (modulation)Weak

Safety

Side effects, stop signs, contraindications

Side effects · 5

  • Nausea, diarrhea and loss of appetite (the most common, cholinergically driven complaints)
  • Sleep disturbance, vivid dreams or nightmares, especially with evening dosing
  • Muscle cramps and muscle twitching
  • Bradycardia (slow heart rate), fainting or dizziness from increased vagal tone
  • Fatigue, headache and weight loss during prolonged treatment

Contraindications · 5

  • Known hypersensitivity to donepezil or piperidine derivatives
  • Sick sinus syndrome, conduction disorders (SA/AV block) or significant bradycardia
  • Active peptic ulcer or high gastrointestinal bleeding risk (increased gastric acid)
  • Asthma or obstructive lung disease: cholinergic action can cause bronchoconstriction
  • During pregnancy and breastfeeding only after medical evaluation

Related Nootropics

Same therapeutic category

Studies

Related research and clinical findings

FAQ

FAQ

Donepezil is an FDA-approved medication used to treat Alzheimer's disease across its mild, moderate, and severe stages. It works by slowing the breakdown of acetylcholine, a brain chemical involved in memory, so more of it stays available, which can improve cognition and daily functioning. Its benefit has been confirmed in large, reliable clinical trials, and it's taken conveniently once a day thanks to its long-lasting effect.

Telegram

Have a question about Donepezil?

Reach out to us on Telegram for a personalized stack. We'll be happy to help.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

Structure & chemistry

TypeNootropic
FormulaC24H29NO3
UpdatedOctober 13, 2026
MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 13, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.